Abciximab (ReoPro) in Acute Ischemic Stroke "ReoPro"

Completed

Phase 2 Results

Limited Information Available

We have very limited information available on this trial, but we keep it in our database for reference and completeness.

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 August 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Lilly Research Laboratories, Indianapolis, IN; Centocor Inc., Malvern, PA

Trial Design

Phase II, randomized, double-blind dose-escalation study of 74 patients at 38 centers.

Contacts

Not available